No. | Age | Sex | Primary site | Subject | Histology of target lesion | Chronic Lung Disorder | Inoperable reason | K-PS (%) | s KL (U/ml) | s SP-D (ng/ml) | VC (L) | FEV1.0 (L) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 75 | M | lung | primary | Adenoca | No | reject | 90 | wnl | wnl | 4.07 | 2.81 |
2 | 83 | M | lung | primary | Unknown | No | TAA/IHD | 90 | wnl | wnl | NA | NA |
3 | 50 | F | rectum | metastasis | Adenoca | post lobectomy | rectal ca. | 90 | wnl | wnl | 3.40 | 2.66 |
4 | 77 | M | lung | recurrence | SCLC | emphysema | SCLC-ED | 90 | wnl | wnl | NA | NA |
5 | 75 | M | lung | primary | Adenoca | No | nephrotic syndrome | 80 | wnl | wnl | NA | NA |
6 | 60 | M | lung | metastasis | Adenoca | post lobectomy | metastasis | 90 | 743 | wnl | 2.61 | 0.59 |
7 | 79 | M | lung | primary | SqCC | emphysema | colon ca./prostate ca. | 90 | wnl | wnl | 1.75 | 1.26 |
8 | 79 | M | ampulla of Vater | metastasis | Unknown | No | metastasis | 80 | wnl | wnl | NA | NA |
9 | 69 | M | lung | recurrence | Aenoca | post partial resection | recurrence | 90 | wnl | wnl | NA | NA |
10 | 84 | M | lung | primary | SqCC | No | TAA | 70 | wnl | wnl | 1.74 | 0.85 |
11 | 81 | M | lung | primary | Adenoca | No | M valve replacement | 80 | wnl | wnl | 3.19 | 2.30 |
12 | 82 | M | lung | primary | SqCC | No | prostate ca. | 80 | wn | wn | 2.50 | 1.75 |
13 | 72 | M | lung | metastasis | SqCC | No | metastasis | 80 | 950 | NA | 2.76 | 2.13 |
14 | 80 | M | lung | primary | Unknown | emphysema | HCC/colon ca. | 80 | NA | NA | NA | NA |
15 | 80 | M | kidney | metastasis | Unknown | No | Renal cell carcinoma | 80 | 529 | wnl | NA | NA |
16 | 60 | M | lung | metastasis | Carcinoma | IP | metastasis | 80 | 852 | NA | 4.01 | 3.24 |
17 | 77 | M | lung | primary | NSCLC | IP | IP | 80 | 1590 | NA | 3.05 | 1.59 |
18 | 68 | M | lung | primary | Adenoca | COPD | COPD | 70 | NA | NA | NA | NA |
19 | 79 | M | lung | primary | SqCC | emphysema | AAA | 90 | 520 | NA | NA | NA |
20 | 64 | F | lung | primary | Adenoca | No | CRF/IHD | 90 | wnl | wnl | 2.04 | 1.56 |
21 | 76 | F | lung | primary | SCLC | No | bladder ca./breast ca. | 90 | wnl | wnl | 2.17 | 1.59 |
22 | 77 | M | lung | primary | SqCC | No | diabetic nephropathy | 80 | wnl | wnl | NA | NA |
23 | 78 | M | lung | primary | NSCLC | IP | IP | 80 | wnl | 127 | NA | NA |
24 | 62 | M | colon | metastasis | Unknown | No | colon ca. | 90 | wnl | wnl | 3.69 | 2.87 |
25 | 78 | F | lung | primary | Carcinoma | IP/post lobectomy | post lobectomy | 90 | wnl | wnl | 1.54 | 0.99 |
(0–500) | (0–110) |